Market Overview: The global market for stroke treatment demonstrated significant strength in 2020 and is anticipated to experience a rapidly increasing revenue compound annual growth rate (CAGR) throughout the forecast period. The rise in the prevalence of chronic illnesses among the growing geriatric population is expected to drive the growth of market revenue. Additionally, the vulnerability of older individuals to strokes, coupled with the escalating consumption of tobacco and the increasing incidence of diabetes, is poised to further boost market growth in the near future.
Stroke is a form of brain attack resulting from reduced or halted blood flow to the brain, causing brain cells to die due to inadequate delivery of nutrients and oxygen. It can affect anyone at any time, with symptoms ranging from ischemic and transient ischemic attacks to hemorrhagic attacks. Ischemic strokes occur due to artery blockages leading to the brain, while hemorrhagic strokes result from the bursting of brain arteries, leading to blood spillage. Brief interruptions in blood flow may cause transient ischemic attacks (TIAs). According to data from the National Stroke Association, stroke ranks as the fifth-largest cause of adult disability and mortality in North America.
Get a sample copy of the Stroke Treatment Market report: https://www.reportsanddata.com/download-free-sample/4279
Market Dynamics: Drivers: The increasing global population at risk of stroke is a significant driver for the stroke diagnostics and treatments market. The growing prevalence of high blood pressure worldwide is a potential factor contributing to the rising number of stroke patients. The expanding geriatric population in both advanced and emerging economies is a key factor placing individuals at risk for stroke. Factors such as physical inactivity, increased smoking, obesity, high cholesterol, and arterial diseases are leading to a higher demand for stroke diagnostics and treatments, propelling market growth.
Rising healthcare spending is another driver expected to accelerate global market growth in the coming years. Developed nations like Germany, the United States, Canada, and the United Kingdom are consistently allocating significant funds to healthcare annually, driven by a global increase in awareness of improved health outcomes and rising per capita income.
Restraints: Stringent government policies regarding the licensing of new technologies and medicines, along with the high cost of treatment, may hinder the stroke treatment market’s share in the near future.
Type Outlook: The global market is segmented into ischemic stroke and hemorrhagic stroke. The hemorrhagic segment is expected to grow rapidly due to the increasing prevalence of hemorrhagic stroke worldwide. The demand for minimally invasive techniques, such as stereotactic radiosurgery for treating ischemic stroke, is also expected to contribute to the growth of the stroke treatment equipment market.
Intracerebral hemorrhage and subarachnoid hemorrhage are the two major forms of hemorrhagic stroke, with intracerebral hemorrhage being the more frequent type. Intracerebral hemorrhages account for 10 to 15% of all strokes, leading to a high demand for hemorrhagic stroke treatment devices.
Drug Class Outlook: The global market is segmented into tissue plasminogen activators (tPA), anticoagulants, antiplatelets, anticonvulsants, and others. Tissue plasminogen activator (tPA) drugs generated the highest revenue in 2018. However, the delay in delivering tPA medications to individuals with acute ischemic stroke may result in health problems. To address this, healthcare providers are being trained to administer tPA medicines within 4.5 hours of the onset of a stroke. Manufacturers are also working on developing novel drug agents with better formulations to minimize the risk of ischemic damage when tPA is administered late.
Distribution Channel Outlook: The global market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to account for the largest revenue share, driven by well-established infrastructure and emergency care services. The increasing demand for stroke treatment devices, especially during emergency cases, is contributing to market growth. Governmental and private sector efforts to reduce hospital charges for various treatments are also driving market growth.
Regional Outlook: North America is expected to register a robust revenue CAGR due to the increasing number of stroke patients in the region. Favorable financing from governments and charity trusts for stroke research, prevention, and treatment in developed nations is a major driver of market growth.
The stroke treatment market in Asia Pacific is anticipated to develop rapidly in the coming years, with India and China becoming profitable marketplaces. The higher incidence of cerebrovascular disorders, hypertension, and diabetes in these countries, coupled with poor lifestyle choices like smoking and improper eating habits, is contributing to market growth.
Companies Profiled in the Report: Key companies in the global market include Sanofi, Daiichi Sankyo Company, Limited., Johnson & Johnson Services, Inc., Amgen Inc., Boehringer Ingelheim GmbH, AstraZeneca, F. Hoffmann-La Roche (Genentech), Bristol-Myers Squibb Company, and Biogen Inc. These key players are investing significantly in technological advancements, production capacity, and strategic alliances such as mergers & acquisitions to cater to growing global demand and strengthen their position in the market.
Notable Developments: Sanofi received U.S. FDA clearance for PLAVIX (clopidogrel bisulfate), an antiplatelet drug intended to lower the risk of heart disease and stroke, in August 2017.
Segments Covered in the Report: This comprehensive report provides historical data points, forecasts, and revenue growth at global, regional, and country levels. It includes analysis of industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution for each regional and country market. The report offers industry analysis, a competitive landscape, company financials, and impact analysis. Detailed views of the global stroke treatment market, changing dynamics and trends, scenarios, market and regional segmentation, regional landscapes, analysis and evaluation, major investments, product offerings, product launches, and historical, current, and projected revenues are also provided.
For the purpose of this report, Reports and Data has segmented the global stroke treatment market based on type, drug class, distribution channel, and region:
Type Outlook (Revenue, USD Billion; 2018-2028):
- Ischemic Stroke
- Hemorrhagic Stroke
Drug Class Outlook (Revenue, USD Billion; 2018-2028):
- Tissue Plasminogen Activators (tPA)
Distribution Channel Outlook (Revenue, USD Billion; 2018-2028):
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Outlook (Revenue, USD Billion; 2018-2028):
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Top of Form
Explore Trending Reports:
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/4279
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release